MRNA:VIE
Moderna Inc
€123.74
arrow_downward
-1.17%(-1.46) 1D
Sep 4, 5:36:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
€127.66
High
€132.10
Low
€123.74
Mkt. cap
58.11B
Avg. vol.
1.01K
Volume
791.00
52-wk high
€139.84
52-wk low
€19.48
No. of employees
5K
Open
€127.66
High
€132.10
Low
€123.74
Mkt. cap
58.11B
Avg. vol.
1.01K
Volume
791.00
52-wk high
€139.84
52-wk low
€19.48
No. of employees
5K
News stories
From web sources and news partners
AD HOC NEWS
·
4 hours ago
Moderna Inc. stock holds steady as investors watch vaccine revenue and oncology pipeline
MarketBeat
·
7 hours ago
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
Yahoo Finance
·
9 hours ago
If You'd Invested in Moderna (MRNA) Stock 5 Years Ago, Here's How Much You'd Have Today (Hint: You'd Be Disappointed -- But Not If You Bought It 1 Year Ago.)
Simply Wall Street
·
1 day ago
Moderna (MRNA) Stock Trades Above Fair Value After Its 479% Run
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
About Moderna Inc